Merck & Co., the second-largest pharmaceutical company in America, agreed to pay $950 million in a settlement with federal prosecutors. The settlement resulted from their "misbranding" of Vioxx, a painkiller which was pulled from the market in 2004 after a study found that it increased heart-attack and stroke cases. The year before it was pulled, Vioxx generated $2.5 billion in sales, making it Merck’s third-most popular drug at that time. Merck already paid $4.85 billion to settle thousands of patient lawsuits claiming injuries, $1.9 billion in legal costs, and $58 million to settle state claims that the company’s TV advertisements were deceptive and covered up health risks. This defective product caused extensive harm for injury victims who suffered personal injuries as a result of Merck’s negligence.